Evidence map›Paper›PMID 39523648›Full record

ArticleParasitology2024

Understanding American tegumentary leishmaniasis in urban Montes Claros, Brazil: insights from clinical, immunological and therapeutic investigations.

Dayse M S Lopes, Jackeline M S Lima, Karine S M Ribeiro, Clarissa F Gomes, Rebeca M Rocha, Thainara S Gonçalves, Thallyta M Vieira, Sílvio F de Carvalho, M G Finn, Ana Paula Venuto and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Parasitology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dayse M S LopesUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.ORCID 0000-0003-2156-2531
Jackeline M S LimaUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Karine S M RibeiroUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Clarissa F GomesUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Rebeca M RochaUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Thainara S GonçalvesUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Thallyta M VieiraUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Sílvio F de CarvalhoUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
M G FinnSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.
Ana Paula VenutoUniversidade Estadual de Montes Claros - Unimontes, Montes Claros, MG, Brazil.
Alexandre F MarquesCenter for Molecular and Cellular Biosciences, School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi, Hattiesburg, MS, USA.ORCID 0000-0001-9416-3465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The challenge of American tegumentary leishmaniasis (ATL) continues in Brazil, presenting a persistent public health issue despite initiatives aimed at public outreach, vector control and health education. To gain a deeper understanding of this disease, a study was conducted in an endemic region located in the northern region of the state of Minas Gerais, Brazil. The study monitored 30 resident patients diagnosed with ATL, using serum samples from 6 healthy individuals as controls. The localized cutaneous form of the disease was found to be predominant, with lesions appearing on various parts of the body and the majority of the affected individuals being male. The study found significantly higher levels of IgG anti-

Indexed as

Leishmaniasis, CutaneousAdolescentAdultAgedAntibodies, ProtozoanAntiprotozoal AgentsBrazilFemaleHumansImmunoglobulin GLeishmaniaLeishmania braziliensisMaleMeglumineMeglumine AntimoniateMiddle AgedAntibodies, ProtozoanAntiprotozoal AgentsImmunoglobulin GMeglumineMeglumine AntimoniateOrganometallic Compoundsalpha-galAmerican tegumentary leishmaniasisLeishmania braziliensisLeishmania infantum

Identifiers

PMID39523648
PMCPMC11894006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.